Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of paeonol oxime ether compound, its preparation method and medical application

An ether compound, paeonol oxime technology, applied in the field of medicinal chemistry and pharmacotherapeutics, can solve the problem of easy sublimation of paeonol

Inactive Publication Date: 2018-08-10
ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The faster metabolic rate of paeonol in the body may be related to its phenolic hydroxyl group. Therefore, we etherified its phenolic hydroxyl group to improve its metabolic stability and overcome the shortcoming of paeonol's easy sublimation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of paeonol oxime ether compound, its preparation method and medical application
  • A kind of paeonol oxime ether compound, its preparation method and medical application
  • A kind of paeonol oxime ether compound, its preparation method and medical application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0122] Preparation of Ethyl Paeonol Ether (1)

[0123]Weigh 2.0g (12mmol) of paeonol and 3.0g (75mmol) of sodium hydroxide in a 100mL round bottom flask, add DMF to dissolve, add bromoethane (1.8mL, 24mmol) dropwise under stirring, and react at 45°C , and TLC monitored the progress of the reaction. After the reaction is complete, add 100 mL of dichloromethane to dilute the reaction solution, wash with saturated brine (50 mL×3), concentrate the organic phase, and separate by column chromatography (the mobile phase is ethyl acetate:petroleum ether (v:v)=1:4) 2.3 g of white solid was obtained, with a yield of 98.2%. m.p.69.5~70.2℃.

[0124] Preparation of ethyl paeonol oxime (2)

[0125] Weigh 2.0g (10.3mmol) of ethylpaeonol ether into a 50mL round bottom flask, add 30mL of absolute ethanol to dissolve, add hydroxylamine hydrochloride (2.1g, 30.9mmol) and pyridine (4mL, 103.0mmol) in turn, 50°C The reaction was stirred, and the progress of the reaction was monitored by TLC. ...

Embodiment 2

[0131] With reference to the method of Example 1, ethyl paeonol oxime was prepared.

[0132] Preparation of ethyl paeonol oxime bromopropyl ether (3)

[0133] Weigh 2.0g (9.5mmol) of ethyl paeonol oxime into a 50mL round bottom flask, add 10ml of DMF to dissolve. Under ice-bath conditions, NaH (0.7g, 28.5mmol) was added, and after stirring for five minutes, 1,3-dibromopropane (28.5mmol) was added, and the reaction was stirred in an ice-bath, and the reaction progress was monitored by TLC. After 0.5 h of reaction, the reaction solution was poured into 100 mL of ice water, extracted with dichloromethane (50 mL×3), the organic phase was washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (ethyl acetate:petroleum ether ( v:v)=1:10) to obtain 2.6 g of colorless oily liquid with a yield of 83.5%.

[0134] Ethylpaeonol oxime 3-(1-morpholinyl)propyl ether (I 9 ) preparation

[0135] Weigh 954 mg (2.9 mmol) of ethox...

Embodiment 3

[0137] With reference to the method of Example 1, ethyl paeonol oxime was prepared.

[0138] Preparation of ethyl paeonol oxime bromobutyl ether (3)

[0139] Weigh 2.0g (9.5mmol) of ethyl paeonol oxime into a 50mL round bottom flask, add 10ml of DMF to dissolve. Under ice-bath conditions, NaH (0.7g, 28.5mmol) was added, and after stirring for five minutes, 1,4-dibromobutane (3.4ml, 28.5mmol) was added, and the reaction was stirred in an ice-bath, and the reaction progress was monitored by TLC. After 0.5 h of reaction, the reaction solution was poured into 100 mL of ice water, extracted with dichloromethane (50 mL×3), the organic phase was washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (ethyl acetate:petroleum ether ( v:v)=1:10) to obtain 2.6 g of colorless oily liquid with a yield of 81.2%.

[0140] Ethylpaeonol oxime 4-[(4-ethyl)-1-piperazinyl]butyl ether (I 18 ) preparation

[0141] Weigh 1.0 g (2.9 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of pharmaceutical chemistry and pharmacotherapeutics, and specifically relates to a paeonol oxime ether compound as well as a preparation method and a pharmaceutical application thereof. The paeonol oxime ether compound has the function of resisting platelet aggregation, and can be used to prepare therapeutic pharmaceuticals for cardiovascular and cerebrovascular diseases. The invention also relates to a preparation method of such paeonol oxime ether compound.

Description

technical field [0001] The present invention relates to the fields of medicinal chemistry and pharmacotherapeutics, in particular to paeonol oxime ether compounds, their preparation methods and their application in pharmacy. The compounds have the effect of anti-platelet aggregation and can be used to prepare medicines for treating cardiovascular and cerebrovascular diseases. The invention also relates to processes for the preparation of such compounds. Background technique [0002] Cardiovascular and cerebrovascular diseases have a very high mortality rate or disability rate, which seriously endanger human life and health. Studies have shown that the pathogenesis of cardiovascular and cerebrovascular diseases is complex, and atherosclerosis (As) is its main pathological basis (Zhongwai Medical, 2011(12):184.). Thrombosis is closely related to atherosclerosis and is one of the important risk factors for atherosclerosis. Traditional Chinese medicine has a long history in t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C251/58C07C249/12C07D295/088A61K31/495A61K31/5375A61K31/4453A61K31/15A61P7/02A61P9/10A61P9/06A61P25/00
CPCC07C251/58C07D295/088
Inventor 何黎琴柏志伟张灼
Owner ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE